Comments and Letters

  • Letter to Marilyn Tavenner regarding PFS Comments

    August 29, 2013
    Administrator Marilyn Tavenner Centers for Medicare and Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue SW Washington, DC 20201 RE: Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, and Other Revisions to Part B for CY 2014, Proposed Rule (CMS-1600-P) Dear Ms. Tavenner, The American Clinical Laboratory AssociationContinue Reading »...
  • AIM Letter to Rep. Speier on Promoting Integrity in Medicare Act of 2013

    August 01, 2013
      The Honorable Jackie Speier U.S. House of Representatives 211 Cannon House Office Building Washington,DC 20515 Dear Representative Speier: On behalf of the members of the Alliance for Integrity in Medicare (AIM) — a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups committed to ending the practice of inappropriate physician self-referral — we thank you for introducing The Promoting IntegrityContinue Reading »...
  • Comment on Promoting Integrity in Medicare Act of 2013

    July 30, 2013
    The Honorable Jackie Speier U.S. House of Representatives 211 Cannon House Office Building Washington, DC 20515 Dear Representative Speier: The American Clinical Laboratory Association (ACLA) represents the nation’s leading local, regional and national laboratories, many of whom provide anatomic pathology services. Therefore, we thank you for introducing The Promoting Integrity in Medicare Act of 2013, which realigns provider incentives to preclude self-referral by noContinue Reading »...
  • Letter from CLC to HHS OIG Meeting Request

    July 11, 2013
      Daniel R. Levinson Inspector General Department of Health and Human Services Office of Inspector General 330 Independence Avenue, SW Washington, DC 20201 Dear Mr. Levinson: On behalf of the undersigned organizations—representing America’s community, regional, hospital-based, and national clinical laboratories; the laboratory professionals who provide care for the Medicare patients we serve; and diagnostic manufacturers—we write to request a meeting with your office toContinue Reading »...
  • Comments Regarding CMS Proposed Requirements for the Medicare Incentive Reward Program and Provider Enrollment

    June 27, 2013
      Marilyn Tavenner, Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attn: CMS-1454-P P.O. Box 8013 Baltimore, Maryland 21244-8013 Re: Proposed Rule: Requirements for the Medicare Incentive Reward Program and Provider Enrollment, CMS-6045-P Dear Ms. Tavenner: The American Clinical Laboratory Association (“ACLA”) is pleased to have the opportunity to submit comments on the Centers for Medicare and Medicaid Services’Continue Reading »...
  • Citizen Petition to FDA Regarding Laboratory Developed Tests (LDTs)

    June 04, 2013
      Division of Dockets Management Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane Room 1061 Rockville, MD 20852 CITIZEN PETITION The American Clinical Laboratory Association (ACLA) submits this petition under the Federal Food, Drug, and Cosmetic Act (FDCA or the Act) to request the Commissioner of Food and Drugs to take the actions described in Section A with respectContinue Reading »...
  • Letter to CMS Regarding Gap Fill

    April 30, 2013
      Marilyn B. Tavenner Administrator Centers for Medicare and Medicaid Services U.S. Department of Health and Human Services 200 Independence Ave., SW Washington, DC 20201 Dear Administrator Tavenner: We are a coalition of patients, providers, clinical laboratories, diagnostic test manufacturers, pharmaceutical companies, and venture capital investors unified in our concern over interim 2013 Medicare Administrative Contractor (MAC) reimbursement rates for molecular diagnostic testing. ThisContinue Reading »...
  • Letter to Sens Baucus and Hatch Regarding Clinical Laboratory Fee Schedule

    April 16, 2013
      The Honorable Max Baucus Chairman, Committee on Finance United States Senate 219 Dirksen Senate Office Building Washington, DC 20510 The Honorable Orrin Hatch Ranking Member, Committee on Finance United States Senate 219 Dirksen Senate Office Building Washington, DC 20510 Dear Chairman Baucus and Ranking Member Hatch: On behalf of the undersigned organizations—representing America’s community, regional, hospital-based, and national clinical laboratories; the laboratory professionalsContinue Reading »...
  • Letter Regarding Gapfilling for Molecular Pathology Tests

    March 27, 2013
      Mr. Marc Hartstein Director, Hospital and Ambulatory Policy Group Centers for Medicare and Medicaid Services Mail Stop C4-01-26 7500 Security Boulevard Baltimore, MD 21244 RE: Gapfilling for Molecular Pathology Tests Dear Marc: I am writing on behalf of ACLA to follow-up on our prior conversations regarding the gapfilling process for new molecular pathology codes, which CMS has mandated. As you know, in theContinue Reading »...
  • Letter to Chairman Baucus and Ranking Member Hatch Regarding Coinsurance

    March 01, 2013
      March 1, 2013 The Honorable Max Baucus Chairman, Committee on Finance U.S. Senate 219 Dirksen Senate Office Building Washington, DC 20510 The Honorable Orrin Hatch Ranking Member, Committee on Finance U.S. Senate 219 Dirksen Senate Office Building Washington, DC 20510 Dear Chairman Baucus and Ranking Member Hatch: We, the undersigned, applaud your leadership in strengthening the Medicare program for current and future beneficiaries.Continue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17